If you purchased TG Therapeutics, Inc. shares between June 4, 2018 and September 25, 2018, have large losses as a result of your trades during this time period, and wish to join this litigation as a potential lead plaintiff, please complete the following Investor Certification.
On October 4, 2018, a class action lawsuit was filed in the United States District Court for the Southern District of New York against TG Therapeutics, Inc. (NASDAQ: TGTX). Federman & Sherwood reminds current and former shareholders of TG Therapeutics, Inc. that they only have until Monday, December 3, 2018 to move the court for appointment as a lead plaintiff in this case. The Complaint alleges violations of Section 10(b) and Section 20(a) of the Securities Exchange Act, and Rule 10b-5 promulgated thereunder.
If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact: Robin Hester at firstname.lastname@example.org